Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Lexicon Pharmaceuticals, Inc. LXRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+222.6%

Lexicon Pharmaceuticals, Inc. (LXRX) has 12 identified peers for comparison in the Healthcare sector. Peers include ARDX, AVRO, BLRX, CWBR, DAWN, EFTR and others.

LXRX has a market capitalization of $788.05M, compared to an average peer market cap of $985.16M.

People Also View

IBRX
IBRX
ImmunityBio, Inc.
$7.78
+2.37%
 TERN
TERN
Terns Pharmaceuticals, Inc.
$52.71
+0.06%
 DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.47
+0.05%
 ARDX
ARDX
Ardelyx, Inc.
$6.30
-0.47%
 MCRB
MCRB
Seres Therapeutics, Inc.
$8.84
+2.67%
 MREO
MREO
Mereo BioPharma Group plc
$0.34
+2.98%
 XFOR
XFOR
X4 Pharmaceuticals, Inc.
$4.33
+3.10%
 ELEV
ELEV
Elevation Oncology, Inc.
$0.37
-2.12%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message